Skip Nav Destination
Article navigation
Erratum|
November 2008
Fospropofol Assay Issues and Impact on Pharmacokinetic and Pharmacodynamic Evaluation: Retracted
James C. Eisenach, M.D.;
James C. Eisenach, M.D.
*Editor-in-Chief, Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina. editor-in-chief@anesthesiology.org.
Search for other works by this author on:
Steven L. Shafer, M.D.;
Steven L. Shafer, M.D.
†Editor-in-Chief, Anesthesia & Analgesia, Palo Alto Veterans Affairs Healthcare System, Palo Alto, California.
Search for other works by this author on:
Brian J. Pollard, M.D.
Brian J. Pollard, M.D.
‡Editor-in-Chief, European Journal of Anaesthesiology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom.
Search for other works by this author on:
Anesthesiology November 2008, Vol. 109, 937.
Citation
James C. Eisenach, Steven L. Shafer, Brian J. Pollard; Fospropofol Assay Issues and Impact on Pharmacokinetic and Pharmacodynamic Evaluation: Retracted. Anesthesiology 2008; 109:937 doi: https://doi.org/10.1097/ALN.0b013e31818ad05e
Download citation file:
Citing articles via
Most Viewed
Related Articles
Fospropofol Assay Issues and Impact on Pharmacokinetic and Pharmacodynamic Evaluation: Retraction
Anesthesiology (April 2010)
Erroneously Published Fospropofol Pharmacokinetic–Pharmacodynamic Data and Retraction of the Affected Publications
Anesthesiology (April 2010)
Fospropofol Assay Issues and Impact on Pharmacokinetic and Pharmacodynamic Evaluation
Anesthesiology (November 2008)
Anesthesiologist Replacements? Fospropofol and CAPS – Update on Patient Safety Issues Related to Sedation by Non-Anesthesiologists
ASA Monitor (October 2008)
Pharmacokinetics and Clinical Pharmacodynamics of the New Propofol Prodrug GPI 15715 in Volunteers: Retraction
Anesthesiology (April 2010)
